STING1 and neoplasm: A pyridinium rotor strategy is proposed to develop a positivelycharged TBTP-Bz, which is stably coincorporated with a STING agonistMSA-2 into thermal-responsive exosome-liposome hybrid nanoparticlesfor tumor-targeting delivery.